Acquired cancer tyrosine kinase inhibitor resistance: ROS as critical determinants

dc.bibliographicCitation.firstPage	437
dc.bibliographicCitation.issue	1
dc.bibliographicCitation.journalTitle	Signal Transduction and Targeted Therapy	eng
dc.bibliographicCitation.volume	6
dc.contributor.author	Bekeschus, Sander
dc.date.accessioned	2023-05-22T07:20:02Z
dc.date.available	2023-05-22T07:20:02Z
dc.date.issued	2021
dc.description.abstract	[No abstract available]	eng
dc.description.version	publishedVersion	eng
dc.identifier.uri	https://oa.tib.eu/renate/handle/123456789/12156
dc.identifier.uri	http://dx.doi.org/10.34657/11189
dc.language.iso	eng
dc.publisher	London : Macmillan Publishers, part of Springer Nature
dc.relation.doi	https://doi.org/10.1038/s41392-021-00844-5
dc.relation.essn	2059-3635
dc.rights.license	CC BY 4.0 Unported
dc.rights.uri	https://creativecommons.org/licenses/by/4.0
dc.subject.ddc	610
dc.subject.other	Carcinoma, Non-Small-Cell Lung	eng
dc.subject.other	Humans	eng
dc.subject.other	Lung Neoplasms	eng
dc.subject.other	Protein Kinase Inhibitors	eng
dc.subject.other	Reactive Oxygen Species	eng
dc.title	Acquired cancer tyrosine kinase inhibitor resistance: ROS as critical determinants	eng
dc.type	Article	eng
dc.type	Text	eng
tib.accessRights	openAccess
wgl.contributor	INP
wgl.subject	Medizin, Gesundheit	ger
wgl.type	Zeitschriftenartikel	ger

Now showing 1 - 1 of 1